A groundbreaking study from APC Microbiome Ireland at University College Cork has unveiled novel insights into the complex interplay between coffee consumption and the gut-brain axis, shedding light on how coffee, both caffeinated and decaffeinated, can enhance gut health and mental wellbeing. This pioneering research, published in Nature Communications, explores the multi-faceted impact of coffee on the microbiome and its consequential effects on mood regulation and stress reduction, offering a new perspective on coffee as a dietary intervention beyond its well-known stimulant properties.
The investigation centered on the bidirectional communication pathways between the gut microbiota and the brain, a field known as the microbiota-gut-brain axis, which has increasingly been recognized as crucial for maintaining overall health. The research aimed to decipher the mechanisms through which habitual coffee intake modulates this axis. Thirty-one habitual coffee drinkers, defined per EFSA guidelines as individuals consuming 3-5 cups per day, were contrasted with an equal number of non-coffee drinkers. Utilizing comprehensive psychological assessments coupled with meticulous monitoring of diet, caffeine intake, and biological sampling, the study tracked changes in gut microbial composition and biochemical metabolites alongside mood and cognitive parameters.
In the first phase, coffee consumption was suspended for two weeks among habitual coffee drinkers, during which profound shifts in microbiome-derived metabolites were detected through analysis of stool and urine samples. This abstinence period revealed marked alterations in the metabolic profiles, distinguishing coffee drinkers from non-coffee drinkers. These findings indicate that habitual coffee intake exerts significant influence on microbial activity within the gut ecosystem, impacting the repertoire of microbial metabolites instrumental in gut-brain communication.
Following this abstinence phase, the study reintroduced coffee administration in a double-blind design, with participants randomized to receive either caffeinated or decaffeinated coffee. Intriguingly, both groups exhibited marked reductions in psychological stress markers and depression indices, underscoring that coffee’s mood-enhancing effects are not solely attributable to caffeine. This challenges the widely held notion that caffeine is the primary psychoactive component of coffee, suggesting other bioactive constituents such as polyphenols play pivotal roles.
Microbial taxa analyses revealed that coffee intake was associated with enhanced proliferation of beneficial bacterial species, including Eggerthella sp. and Cryptobacterium curtum. Eggerthella is implicated in modulating gastric and intestinal acid secretion, vital for maintaining digestive homeostasis and pathogen resistance, while Cryptobacterium curtum contributes to bile acid metabolism, a process important for lipid digestion and gut microbial balance. Increased abundance of Firmicutes was also observed; this phylum has been linked in previous studies to positive emotional states, particularly among females, reinforcing the gut microbiota’s role in psychological resilience.
The neuropsychological assessments yielded differential outcomes dependent on coffee type. Decaffeinated coffee consumption correlated with improvements in cognitive domains such as learning and memory, suggesting that compounds independent of caffeine—possibly antioxidant polyphenols—exert neuroprotective or cognitive-enhancing effects. Conversely, caffeinated coffee intake was uniquely associated with decreased anxiety levels and enhanced alertness, vigilance, and attention. Additionally, caffeine’s anti-inflammatory properties were supported by biological markers indicating reduced systemic inflammation, highlighting caffeine’s multifaceted role in brain function and immune modulation.
Professor John Cryan, principal investigator of the study, emphasized that these findings provide unprecedented mechanistic insight into how coffee consumption can beneficially recalibrate the microbiome and its metabolic outputs to influence brain function and mental health. He noted the increasing public fascination with gut health and its complex links to mental wellbeing, highlighting coffee’s potential utility as an accessible dietary strategy to support both digestive and neurological health through microbiome-mediated pathways.
This research marks a significant advancement in nutritional neuroscience by elucidating how coffee, a globally consumed beverage, transcends its conventional caffeine-centric narrative. It positions coffee as a complex dietary matrix that interacts with gut microbial communities, modulates metabolite profiles, and influences cognitive and emotional outcomes through both shared and distinct mechanisms depending on caffeine presence. These insights pave the way for future interventions targeting the gut-brain axis through tailored coffee-based regimens to optimize mental and digestive wellbeing.
Moreover, the study’s rigorous methodology—including microbiome sequencing, metabolomics, psychological evaluations, and stringent dietary monitoring—sets a benchmark for future investigations into dietary influences on the microbiota-gut-brain axis. It also exemplifies the power of interdisciplinary approaches combining microbiology, neuropsychology, and nutritional science to unravel the intricate relationships between diet, microbes, and mental health.
While these findings are compelling, the authors note the need for larger cohort studies to validate and expand upon these results, particularly in clinical populations with gut or mood disorders. Understanding the dose-response effects, the contribution of specific bioactive compounds in coffee, and long-term impacts on the microbiome-brain crosstalk remain critical areas for future research.
In summary, this study compellingly demonstrates that regular coffee consumption, whether caffeinated or decaffeinated, can reshape the gut microbiome and its metabolite production to foster improved mood, reduced stress, cognitive enhancements, and potentially diminished inflammation. This underscores coffee’s role not just as a widely enjoyed beverage but as a functional dietary component with profound implications for gut and brain health.
Subject of Research: People
Article Title: Coffee’s Influence on the Gut-Brain Axis: Microbiome and Mood Regulation Mechanisms
News Publication Date: 21-Apr-2026
Web References:
APC Microbiome Ireland: https://www.ucc.ie/en/apc/
European Food Safety Authority (EFSA) Caffeine Safety Opinion: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4102
Institute for Scientific Information on Coffee (ISIC): https://www.coffeeandhealth.org/
References:
Cryan, J.F. et al. (2026). Nature Communications. DOI: 10.1038/s41467-026-71264-8
EFSA (2015). Scientific Opinion on the Safety of Caffeine, EFSA Journal, 13(5):4102.
Image Credits: APC Microbiome Ireland, University College Cork
Keywords
Gut microbiome, coffee, caffeine, decaffeinated coffee, microbiota-gut-brain axis, mood regulation, stress reduction, polyphenols, cognitive enhancement, microbiome metabolites, inflammation, psychological wellbeing
Tags: APC Microbiome Ireland studycaffeine and decaffeinated coffee benefitscoffee and cognitive functioncoffee and gut health connectioncoffee and mood regulationcoffee consumption and microbiomecoffee intake and stress reductiondietary interventions for gut healtheffects of coffee on mental wellbeinggut-brain axis and coffeehabitual coffee drinking impactmicrobiota-gut-brain communication
